2. 1Q10 Earnings Release
Highlights For The Period
• Gross revenue reached R$ 766.0 million, showing a 15.8% growth when comparing with the same period of the
previous year;
• Net profit of the Company increased 15.1% in relation to the same period of the previous year, reaching R$ 7.8
million, representing a net margin of 1.2%;
• A 7.8% reduction of the operating expenses, reaching 7.5% of the net operating revenue, representing a reduction
of 0.7 percentage point in relation with the same period of the previous year;
• Improvement of the service level, reaching 92.3%, an increase of 1.6 percentage point in relation to the same period
of the previous year when we reached 90.7%;
• Increase of the annual price occurred on March 31st, 2010 was of 4.5% in line with inflation accumulated in the past
12 months, being the second largest increase in the last four years.
6. 1Q10 Earnings Release
Gross Profit and Revenues from Services to Suppliers
(R$ million and as % Net Revenues)
11.2% 11.0%
10.4%
18.6
5.3
20.0
57.8
57.1
46.5
1Q09 4Q09 1Q10
Gross Profit Revenues from Services to Suppliers Gross Profit Margin (%)
6
7. 1Q10 Earnings Release
Operating Expenses
(R$ million and as % Net Revenues )
8.2%
7.4% 7.5%
50.6
48.1
45.9
1Q09 4Q09 1Q10
7
8. 1Q10 Earnings Release
Net Financial Expenses
(R$ million and as % Net Revenues)
1.4%
0.8% 0.8%
7.8
5.3 5.4
1Q09 4Q09 1Q10
8
9. 1Q10 Earnings Release
Net Profit
(R$ million and as % Net Revenues)
2.2%
1.2% 1.2%
15.4
7.8
6.7
1Q09 4Q09 1Q10
9
10. 1Q10 Earnings Release
Ebitda and Ebitda Margin
(R$ million and as % Net Revenues)
4.1%
3.0% 2,8%
28.0
17.9
17.1
1Q09 4Q09 1Q10
10
18. IR Contacts
Max Fischer
CFO and IR Director
Beatriz Diez
IR Manager
Telephone,: 55 (21) 4009 0276
E-mail: ri@profarma.com.br
www.profarma.com.br/ir
